GB9917144D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB9917144D0
GB9917144D0 GBGB9917144.9A GB9917144A GB9917144D0 GB 9917144 D0 GB9917144 D0 GB 9917144D0 GB 9917144 A GB9917144 A GB 9917144A GB 9917144 D0 GB9917144 D0 GB 9917144D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9917144.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9917144.9A priority Critical patent/GB9917144D0/en
Publication of GB9917144D0 publication Critical patent/GB9917144D0/en
Priority to PCT/EP2000/001456 priority patent/WO2000050461A1/en
Priority to TR2001/02493T priority patent/TR200102493T2/en
Priority to CZ20013081A priority patent/CZ20013081A3/en
Priority to HU0105490A priority patent/HUP0105490A3/en
Priority to IL14502500A priority patent/IL145025A0/en
Priority to EP00910690A priority patent/EP1155038A1/en
Priority to BR0008964-8A priority patent/BR0008964A/en
Priority to NZ513680A priority patent/NZ513680A/en
Priority to PL00350992A priority patent/PL350992A1/en
Priority to CA002363641A priority patent/CA2363641A1/en
Priority to AU32811/00A priority patent/AU3281100A/en
Priority to JP2000601039A priority patent/JP2002537403A/en
Priority to MXPA01008612A priority patent/MXPA01008612A/en
Priority to CNA008067562A priority patent/CN1520423A/en
Priority to KR1020017010940A priority patent/KR20020007314A/en
Priority to CO00013386A priority patent/CO5231139A1/en
Priority to ARP000100821A priority patent/AR029619A1/en
Priority to NO20014131A priority patent/NO20014131L/en
Priority to HK02103181.1A priority patent/HK1043134A1/en
Priority to US10/304,443 priority patent/US20030170229A1/en
Priority to US10/322,210 priority patent/US20030147906A1/en
Priority to US11/004,771 priority patent/US20050152892A1/en
Ceased legal-status Critical Current

Links

GBGB9917144.9A 1999-02-25 1999-07-21 Vaccine Ceased GB9917144D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GBGB9917144.9A GB9917144D0 (en) 1999-07-21 1999-07-21 Vaccine
KR1020017010940A KR20020007314A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
CA002363641A CA2363641A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
JP2000601039A JP2002537403A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes from the C-epsilon-3 or C-epsilon-4 domain of IgE, antagonists thereof, and their therapeutic uses
CZ20013081A CZ20013081A3 (en) 1999-02-25 2000-02-22 Epitopes and a extratopes obtained from C-epsilon-2 region or C-epsilon-4 IgE region, their antagonists a their therapeutic use
HU0105490A HUP0105490A3 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
IL14502500A IL145025A0 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
EP00910690A EP1155038A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
BR0008964-8A BR0008964A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the ige dec-epsilon-3 or c-epsilon-4 fields, antagonists of the same and their therapeutic uses
NZ513680A NZ513680A (en) 1999-02-25 2000-02-22 Epitodes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses
PL00350992A PL350992A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
PCT/EP2000/001456 WO2000050461A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
AU32811/00A AU3281100A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
TR2001/02493T TR200102493T2 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE.
MXPA01008612A MXPA01008612A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses.
CNA008067562A CN1520423A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from C-eqsilon-3, or C-epsilon-4 domains of ige, antagonists thereof, and their thera peutic uses
ARP000100821A AR029619A1 (en) 1999-02-25 2000-02-25 VACCINE
CO00013386A CO5231139A1 (en) 1999-02-25 2000-02-25 ALLERGIC VACCINE
NO20014131A NO20014131L (en) 1999-02-25 2001-08-24 Epitopes or mimotopes derived from C-epsilon-3 or C-epsilon-4 domains from IgE, antagonists thereof, and derester therapeutic applications
HK02103181.1A HK1043134A1 (en) 1999-02-25 2002-04-29 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
US10/304,443 US20030170229A1 (en) 1999-02-25 2002-11-26 Vaccine
US10/322,210 US20030147906A1 (en) 1999-07-21 2002-12-18 Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of lgE, antagonists thereof, and their therapeutic uses
US11/004,771 US20050152892A1 (en) 1999-07-21 2004-12-03 Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutics uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9917144.9A GB9917144D0 (en) 1999-07-21 1999-07-21 Vaccine

Publications (1)

Publication Number Publication Date
GB9917144D0 true GB9917144D0 (en) 1999-09-22

Family

ID=10857685

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9917144.9A Ceased GB9917144D0 (en) 1999-02-25 1999-07-21 Vaccine

Country Status (1)

Country Link
GB (1) GB9917144D0 (en)

Similar Documents

Publication Publication Date Title
IL145044A0 (en) Vaccine
HUS1300072I1 (en) Vaccine
HUP0202885A3 (en) Vaccines
HK1105581A1 (en) Vaccine composition
EP1083926A4 (en) Vaccine
GB9910812D0 (en) Vaccine composition
GB9915204D0 (en) Vaccine
GB9901254D0 (en) Vaccines
GB0027072D0 (en) Vaccine
GB9906437D0 (en) Vaccine
GB9913327D0 (en) Vaccine
MXPA01010701A (en) Vaccine.
GB9930591D0 (en) Component for vaccine
GB9909072D0 (en) Vaccine
GB9930585D0 (en) Component for vaccine
GB9917144D0 (en) Vaccine
GB9915106D0 (en) Vaccine
GB9925619D0 (en) Vaccine
GB9925618D0 (en) Vaccine
GB9922703D0 (en) Vaccine
GB9904405D0 (en) Vaccine
GB9904408D0 (en) Vaccine
GB9904412D0 (en) Vaccine
GB9922701D0 (en) Vaccine
GB9905511D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)